Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
1967 1
1968 2
1969 4
1970 6
1971 4
1972 11
1973 15
1974 15
1975 8
1976 4
1977 9
1978 13
1979 14
1980 15
1981 13
1982 15
1983 23
1984 19
1985 25
1986 21
1987 26
1988 29
1989 44
1990 45
1991 43
1992 44
1993 43
1994 51
1995 72
1996 69
1997 79
1998 98
1999 128
2000 177
2001 156
2002 159
2003 210
2004 205
2005 232
2006 209
2007 227
2008 226
2009 260
2010 240
2011 225
2012 202
2013 223
2014 233
2015 210
2016 182
2017 163
2018 145
2019 59
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

4,631 results
Results by year
Filters applied: . Clear all
Page 1
[Reconsidering on the drug therapy of adult laryngopharyngeal reflux disease].
Hu JJ, et al. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2018 - Review. PMID 30122007 Chinese.
The treatment for laryngopharyngeal reflux diseases consist of general treatment, medical therapy and surgical treatment, among which, drug therapy is still the main effective way. ...With standardized treatment, the majority of symptoms in laryngopharyngeal reflux disease could be alleviated effectively. PPI therapy, while seeming logical, is less useful in patients with reflux hypersensitivity, weak acid or non acid reflux, neuropsychic factors and gastroesophageal reflux disease. ...
The treatment for laryngopharyngeal reflux diseases consist of general treatment, medical therapy and surgical treatment, amon …
Gastroesophageal Reflux Disease (GERD).
Clarrett DM and Hachem C. Mo Med 2018 - Review. PMID 30228725 Free PMC article.
Gastroesophageal reflux disease (GERD) is a common clinical problem, affecting millions of people worldwide. Patients are recognized by both classic and atypical symptoms. Acid suppressive therapy provides symptomatic relief and prevents complications in many individuals with GERD. Advances in diagnostic and therapeutic modalities have improved our ability to identify and manage disease complications. ...
Gastroesophageal reflux disease (GERD) is a common clinical problem, affecting millions of people worldwide. Patients are reco
Proton Pump Inhibitor-Refractory Gastroesophageal Reflux Disease.
Yadlapati R and DeLay K. Med Clin North Am 2019 - Review. PMID 30466671 Free PMC article.
Proton pump inhibitor (PPI)-refractory gastroesophageal reflux disease (GERD) is defined by the presence of troublesome GERD symptoms despite PPI optimization for at least 8 weeks in the setting of ongoing documented pathologic gastroesophageal reflux. It arises from a dysfunction in protective systems to prevent reflux and as propagation of physiologic reflux events. Treatment possibilities include pharmacologic options, invasive management strategies, and endoluminal therapies. ...
Proton pump inhibitor (PPI)-refractory gastroesophageal reflux disease (GERD) is defined by the presence of troublesome GERD s …
Medical treatment of gastroesophageal reflux disease.
Bor S and Kalkan İH. Turk J Gastroenterol 2017 - Review. PMID 29199168 Free article.
Proton pump inhibitors (PPIs) are the most effective agents in the first-line and maintenance treatment of gastroesophageal reflux disease. ...In patients who use PPIs for a long time, the drug must be stopped by gradually decreasing the dose....
Proton pump inhibitors (PPIs) are the most effective agents in the first-line and maintenance treatment of gastroesophageal reflux
Prokinetics and their use in gastroenterology
Dolina J, et al. Vnitr Lek 2018 - Review. PMID 30223666
In addition to isolated administering of prokinetics, they can also be used in combination with other drugs, for example in the treatment of gastroesophageal reflux disease with proton pump inhibitors. ...Key words: gastroesophageal reflux disease - gastrointestinal dysmotility - gastroparesis - intestinal pseudo-obstruction - obstipation....
In addition to isolated administering of prokinetics, they can also be used in combination with other drugs, for example in the treatment of …
Introduction
Illueca M. J Pediatr Gastroenterol Nutr 2015. PMID 26422092
Review of antireflux procedures for proton pump inhibitor nonresponsive gastroesophageal reflux disease.
Hillman L, et al. Dis Esophagus 2017 - Review. PMID 28859357 Free PMC article.
Up to 40% of patients with gastroesophageal reflux disease (GERD) report persistent symptoms despite proton pump inhibitor (PPI) therapy. ...
Up to 40% of patients with gastroesophageal reflux disease (GERD) report persistent symptoms despite proton pump inhibitor (PP …
[Alginates in therapy for gastroesophageal reflux disease].
Avdeev VG. Ter Arkh 2015 - Review. PMID 26155630 Russian.
This article presents evidence of the prevalence of gastroesophageal reflux disease (GERD) and highlights its main treatment options. ...
This article presents evidence of the prevalence of gastroesophageal reflux disease (GERD) and highlights its main treatment o …
[Differentiation therapy for non-acidic gastroesophageal reflux disease].
Lishchuk NB, et al. Ter Arkh 2017. PMID 28514401 Russian.
AIM: To investigate the clinical and pathogenetic features of the non-acidic types of gastroesophageal reflux disease (GERD) and to evaluate the impact of combined therapy versus monotherapy on the course of this disease. ...The patients were divided into 2 groups: 1) weakly acidic gastroesophageal refluxes (GER); 2) weakly alkaline GER. Then each group was distributed, thus making up 4 groups: 1) 19 patients with weakly acidic GER who received monotherapy with rabeprazole 20 mg/day; 2) 21 patients with weakly acidic GER had combined therapy with rabeprazole 20 mg and itopride; 3) 8 patients with weakly alkaline GER who received ursodeoxycholic acid (UDCA) monotherapy; and 4) 14 patients with weakly alkaline GER who had combined therapy with UDCA and itopride, The clinical symptoms of the disease, the endoscopic pattern of the upper gastrointestinal tract (GIT) mucosa, histological changes in the esophageal and gastric mucosa, and the results of 24-hour impedance pH monitoring were assessed over time. ...
AIM: To investigate the clinical and pathogenetic features of the non-acidic types of gastroesophageal reflux disease (GERD) a …
4,631 results
Jump to page
Feedback